3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Prolymphocytic, B-Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Biphenotypic, Acute
1
Kidney Neoplasms
1
Glioma
1
Colorectal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Interventions
Temozolomide
23
Radiotherapy
10
Magnetic Resonance Spectroscopy
10
Radiation
8
Specimen Handling
7
Lomustine
4
Bevacizumab
4
Nivolumab
3
Biopsy
3
veliparib
2
trametinib
2
olaparib
2
lutetium Lu 177 dotatate
2
dabrafenib
2
cemiplimab
2
azeliragon
2
Surgical Procedures, Operative
2
Receptors, Interleukin-8B
2
Photons
2
Palliative Care
2
Ipilimumab
2
D2C7-(scdsFv)-PE38KDEL
2
CTLA-4 Antigen
2
Aminolevulinic Acid
2
vocimagene amiretrorepvec
1
varlilumab
1
ulixertinib
1
tinostamustine
1
temsirolimus
1
senicapoc
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Blood Component Removal
×
30 days
×
Clear all
No trials found.